Deirdre Connelly
Board Member
Sarepta Therapeutics, Inc. (SRPT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Deirdre Connelly
Deirdre Connelly is recorded as Board Member at Sarepta Therapeutics, Inc. (SRPT). Sarepta Therapeutics, Inc. reported in an 8-K filed June 4, 2026 that Deirdre Connelly was appointed director, effective June 4, 2026. Sarepta Therapeutics, Inc. reported in an 8-K filed September 16, 2024 that Deirdre Connelly was appointed director, effective September 12, 2024.
“The director nominees listed below were elected to serve on the Company’s board of directors as members of Class I for a term of two years.”
“On September 12, 2024, the board of directors (the "Board") of Sarepta Therapeutics, Inc. (the "Company") appointed Deirdre Connelly as a director of the Company, effective immediately, to serve as a member of Class I until the 2026 annual meeting of stockholders.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sarepta Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Douglas Ingram CEO, Board Member
- Michael Severino, M.D. CEO, Board Member
- M. Kathleen Behrens Chairman
- Ryan H. Wong CFO
- Ian Estepan COO, Chief Accounting Officer
- Ian M. Estepan COO
- Cristin L. Rothfuss General Counsel
- Claude Nicaise Board Member
- Claude Nicaise, M.D. Board Member
- Douglas S. Ingram Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.